Looks like you’re on the UK site. Choose another location to see content specific to your location
Agilent Technologies launches new fluorescent in situ hybridisation assays
Agilent Technologies has announced the introduction of SureFISH probes, a new range of fluorescent in situ hybridisation (FISH) assays for use in molecular analysis.
The new class I analyte-specific reagents offer higher resolution and faster hybridisation times than existing FISH products, allowing users to specifically detect aberrations in regions of the genome as small as 50kb.
Aberrations near highly repetitive regions can also be identified with much greater ease than with rival products, allowing previously difficult genomic analyses to be carried out with simplicity.
The initial menu includes SureFISH probes for hundreds of the most common regions, with additional assays to be introduced later this year.
Robert Schueren, Agilent's vice-president and general manager for genomics, said: "We're making a major impact in the cytogenetics community with a comprehensive portfolio of high-performance products that enable cytogenetic researchers to choose a molecular analysis method that best fits their needs."
Earlier this month, the company introduced its new 1260 Infinity Hybrid SFC/UHPLC system, a revolutionary device combining supercritical fluid chromatography and ultra high-performance liquid chromatography capabilities.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard